<h3>漲幅榜</h3>
<ul>
<li><strong>新細胞醫學</strong> (NASDAQ: GDTC) 的股票在週四的盤前交易中上漲了 27.1%，至$1.08。其流通股的市場價值為 990 萬美元。</li>
<li><strong>安博生物科技</strong> (NASDAQ: NNNN) 的股票上漲了 18.15%，至$27.21。其流通股的市場價值為 10 億美元。</li>
<li><strong>ALX 腫瘤學控股</strong> (NASDAQ: ALXO) 的股票上漲了 16.41%，至$2.34。公司的市值為 2.637 億美元。</li>
<li><strong>Nexalin 科技</strong> (NASDAQ: NXL) 的股票上漲了 16.19%，至$0.66。其流通股的市場價值為 1050 萬美元。</li>
<li><strong>Can Fite 生物製藥</strong> (AMEX: CANF) 的股票上漲了 15.34%，至$4.66。公司的市值為 520 萬美元。</li>
<li><strong>愛齊科技</strong> (NASDAQ: ALGN) 的股票上漲了 10.43%，至$178.13。公司的市值為 116 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>ENDRA 生命科學</strong> (NASDAQ: NDRA) 的股票在週四的盤前交易中下跌了 11.8%，至$3.43。其流通股的市場價值為 450 萬美元。</li>
<li><strong>Omnicell</strong> (NASDAQ: OMCL) 的股票下跌了 11.12%，至$41.5。公司的市值為 21 億美元。根據新聞稿，第四季度的財報今天發佈。</li>
<li><strong>Agape ATP</strong> (NASDAQ: ATPC) 的股票下跌了 9.05%，至$0.08。其流通股的市場價值為 420 萬美元。</li>
<li><strong>TuHURA 生物科學</strong> (NASDAQ: HURA) 的股票下跌了 8.93%，至$0.42。其流通股的市場價值為 2610 萬美元。</li>
<li><strong>Accuray</strong> (NASDAQ: ARAY) 的股票下跌了 7.82%，至$0.7。其流通股的市場價值為 8570 萬美元。根據新聞稿，第二季度的財報昨天發佈。</li>
<li><strong>Tempest Therapeutics</strong> (NASDAQ: TPST) 的股票下跌了 7.57%，至$2.2。公司的市值為 1170 萬美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>

ATPC

標普生物技術 ETF - SPDR

OMCL

<p>在週四的盤前交易中，幾隻醫療股票出現了顯著波動。漲幅較大的股票包括 CytoMed Therapeutics（上漲 27.1%，至 1.08 美元）、Anbio Biotechnology（上漲 18.15%，至 27.21 美元）和 ALX Oncology Holdings（上漲 16.41%，至 2.34 美元）。相反，跌幅較大的股票包括 ENDRA Life Sciences（下跌 11.8%，至 3.43 美元）、Omnicell（下跌 11.12%，至 41.5 美元）和 Agape ATP（下跌 9.05%，至 0.08 美元）。這些公司的市值各不相同，Align Technology 的市值為 116 億美元，而 Nexalin Technology 和 Can Fite Biopharma 等公司的估值則較低</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>漲幅榜</h3>
</div><ul>
<li><strong>CytoMed Therapeutics</strong> (NASDAQ: GDTC) shares increased by 27.1% to $1.08 during Thursday's pre-market session. The market value of their outstanding shares is at $9.9 million.</li>
<li><strong>Anbio Biotechnology</strong> (NASDAQ: NNNN) stock increased by 18.15% to $27.21. The market value of their outstanding shares is at $1.0 billion.</li>
<li><strong>ALX Oncology Holdings</strong> (NASDAQ: ALXO) shares moved upwards by 16.41% to $2.34. The company's market cap stands at $263.7 million.</li>
<li><strong>Nexalin Technology</strong> (NASDAQ: NXL) stock moved upwards by 16.19% to $0.66. The market value of their outstanding shares is at $10.5 million.</li>
<li><strong>Can Fite Biopharma</strong> (AMEX: CANF) shares moved upwards by 15.34% to $4.66. The company's market cap stands at $5.2 million.</li>
<li><strong>Align Technology</strong> (NASDAQ: ALGN) shares moved upwards by 10.43% to $178.13. The company's market cap stands at $11.6 billion. As per the press release, Q4 earnings came out yesterday.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>新細胞醫學</strong> (NASDAQ: GDTC) 的股票在週四的盤前交易中上漲了 27.1%，至$1.08。其流通股的市場價值為 990 萬美元。</li>
<li><strong>安博生物科技</strong> (NASDAQ: NNNN) 的股票上漲了 18.15%，至$27.21。其流通股的市場價值為 10 億美元。</li>
<li><strong>ALX 腫瘤學控股</strong> (NASDAQ: ALXO) 的股票上漲了 16.41%，至$2.34。公司的市值為 2.637 億美元。</li>
<li><strong>Nexalin 科技</strong> (NASDAQ: NXL) 的股票上漲了 16.19%，至$0.66。其流通股的市場價值為 1050 萬美元。</li>
<li><strong>Can Fite 生物製藥</strong> (AMEX: CANF) 的股票上漲了 15.34%，至$4.66。公司的市值為 520 萬美元。</li>
<li><strong>愛齊科技</strong> (NASDAQ: ALGN) 的股票上漲了 10.43%，至$178.13。公司的市值為 116 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>ENDRA Life Sciences</strong> (NASDAQ: NDRA) shares decreased by 11.8% to $3.43 during Thursday's pre-market session. The market value of their outstanding shares is at $4.5 million.</li>
<li><strong>Omnicell</strong> (NASDAQ: OMCL) shares decreased by 11.12% to $41.5. The company's market cap stands at $2.1 billion. As per the press release, Q4 earnings came out today.</li>
<li><strong>Agape ATP</strong> (NASDAQ: ATPC) shares declined by 9.05% to $0.08. The market value of their outstanding shares is at $4.2 million.</li>
<li><strong>TuHURA Biosciences</strong> (NASDAQ: HURA) shares fell 8.93% to $0.42. The market value of their outstanding shares is at $26.1 million.</li>
<li><strong>Accuray</strong> (NASDAQ: ARAY) shares fell 7.82% to $0.7. The market value of their outstanding shares is at $85.7 million. As per the press release, Q2 earnings came out yesterday.</li>
<li><strong>Tempest Therapeutics</strong> (NASDAQ: TPST) shares decreased by 7.57% to $2.2. The company's market cap stands at $11.7 million.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>ENDRA 生命科學</strong> (NASDAQ: NDRA) 的股票在週四的盤前交易中下跌了 11.8%，至$3.43。其流通股的市場價值為 450 萬美元。</li>
<li><strong>Omnicell</strong> (NASDAQ: OMCL) 的股票下跌了 11.12%，至$41.5。公司的市值為 21 億美元。根據新聞稿，第四季度的財報今天發佈。</li>
<li><strong>Agape ATP</strong> (NASDAQ: ATPC) 的股票下跌了 9.05%，至$0.08。其流通股的市場價值為 420 萬美元。</li>
<li><strong>TuHURA 生物科學</strong> (NASDAQ: HURA) 的股票下跌了 8.93%，至$0.42。其流通股的市場價值為 2610 萬美元。</li>
<li><strong>Accuray</strong> (NASDAQ: ARAY) 的股票下跌了 7.82%，至$0.7。其流通股的市場價值為 8570 萬美元。根據新聞稿，第二季度的財報昨天發佈。</li>
<li><strong>Tempest Therapeutics</strong> (NASDAQ: TPST) 的股票下跌了 7.57%，至$2.2。公司的市值為 1170 萬美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>
</div>

12 只醫療保健股票在週四盤前交易時段出現波動